Nabumetone
Product Images NDC 66267-482

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 66267-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)
6-methoxy-2-naphthylacetic acid (6MNA) is a chemical compound with the molecular formula COOH-CH40.*
FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)
The text provides information on a study conducted on young adults and elderly individuals, comparing the mean and standard deviation of various measurements (Trax, tyyp, Clgg/F, and VdgofF) at 1,000 mg and 2,000 mg doses. The study had a sample size of n=31 for young adults at 1,000 mg, n=12 for young adults at 2,000 mg, and n=27 for elderly individuals at 1,000 mg.*
FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)
This is a graph plotting the plasma concentrations of Nabumetone Active Metabolite (6MNA) at steady state after once-daily doses of either 1000mg or 2000mg nabumetone. The graph shows the mean concentration levels for each group of participants, as well as the +2SD and -2SD levels for the 1000mg group. The X-axis plots time in hours, and the Y-axis plots the plasma concentration levels in ng/mL. No further information is available.*
FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)
This is a list of different forms of molecules and their percentages after a dose has been given. The molecules listed are nabumetone, 6-methoxy-2-naphthylacetic acid (6MNA), 6-hydroxy-2-naphthylacetic acid (6HNA), and 4-(6-hydroxy-2-naphthyl)-butan-2-ol, along with unidentified minor metabolites. The percentages range from not detectable to 73% for the different molecules.*
FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)
This appears to be a table showing the Mean/Mode Duration of treatment (in years) along with the Dose, Number of Patients, and their condition (RA) for Nabumetone. The table includes various dosages of Nabumetone (500mg, 1000mg, 1500mg, and 2000mg) along with the corresponding number of patients and the mean/mode duration of their treatment.*
FDA Label Image

Pdp (66267 482 60 A117)

Pdp (66267 482 60 A117)
This is a product description for tablets of Nabumetone 500mg, a nonsteroidal anti-inflammatory drug used to relieve pain and inflammation associated with arthritis. The tablets are manufactured by an unidentified pharmaceutical company, and the lot number of these is 000000 with an expiration date of 00-00. The tablets are available only with a prescription (Rx). The product should be stored at a controlled temperature of 63.77°F and kept out of the reach of children.*
FDA Label Image

Structural Formula Of Nabumetone (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.